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ABSTRACT
The Victorian Institute of Sport Assessment (VISA) questionnaire model is based
on item response theory using a graded response (responses reflect increasing
difficulty). The purpose of the VISA-G is to monitor patient outcomes and evaluate
treatment strategies for people with greater trochanteric pain syndrome (GTPS).
The primary aim of the current study was to translate and culturally adapt the
VISA-G into a Danish context (DK) through forward and back translation and
cognitive interviews. The second aim was to establish test–retest reliability and face
validity of the VISA-G into a Danish context (DK). No major disagreements were
observed between the original and translated versions of the questionnaire. A total
of 58 heterogenous asymptomatic, and 49 symptomatic respondents (response
rate: 92% and 78% respectively) completed the VISA-G.DK twice, 1 week
apart. The VISA-G.DK had excellent internal consistency (Cronbach’s alpha:
asymptomatic = 0.86; symptomatic = 0.98). The test–retest reliability was excellent
for the total score: ICC: 0.961 (95% CI [0.933–0.978]). Standard Error Measurement
was calculated to be 0.6. Bland–Altman plots showed no significant or relevant
differences from test to retest in the total score with mean differences below 1 (0.61).
The minimal detectable change was 3.17 for both groups. The VISA-G.DK was found
to be valid, reliable and acceptable for use in the Danish population.
Subjects Anatomy and Physiology, Orthopedics, Rheumatology
Keywords VISA-G.DK, Hip pain, Lateral, Musculskeletal, Pain, Hip function
BACKGROUND
Greater trochanteric pain syndrome (GTPS), previously known as trochanteric bursitis, is
relatively common, affecting between 10% and 25% of the older population (Segal et al.,
2007; Lievense et al., 2005). GTPS negatively affects sleep quality, physical activity,
work participation and overall quality of life (Fearon et al., 2014a); it can be hard to treat
effectively (Lequesne et al., 2008; Bird et al., 2001). A recent study found the prevalence of
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GTPS in Denmark to be 2.9 per 1,000 patients, with patients having a mean age of
50.8 years, and consistent with other studies, women making up 73% of the participants.
Due to the impact that GTPS has on patients and its prevalence, it is appropriate to
facilitate the use of an appropriate patient-reported outcome measure (PROM) to evaluate
the effectiveness of treatment of GTPS in a Danish setting (Riel et al., 2019).
The expression GTPS has been coined to recognise several disorders around the
lateral hip that may produce lateral hip pain: including trochanteric bursitis, and,
tendinopathy and tears of the gluteus medius and minimus tendons (Lequesne et al., 2008;
Connell et al., 2003). Two or more of these pathologies often co-existing (Lequesne et al.,
2008; Connell et al., 2003). The aetiology of GTPS is not fully understood, and likely
relates to myofascial pain rather than solely inflammation (Segal et al., 2007; Fearon et al.,
2014b). Patient’s typically present with pain on weight-bearing and reproducible
tenderness in the region of the greater trochanter, buttock, or lateral thigh. While people
with GTPS generally respond to some extent to conservative measures (Barratt, Brookes &
Newson, 2017; Mellor et al., 2018; Ganderton et al., 2016; Furia, Rompe & Maffulli,
2009; Rompe et al., 2009), it can be challenging to treat (Lequesne et al., 2008; Bird et al.,
2001) and surgical intervention may be necessary in obstinate cases (Lustenberger et al.,
2011). A recent SR and meta-analysis noted the need for further high-quality studies to
determine the most effective treatment for GTPS (Barratt, Brookes & Newson, 2017).
High-quality studies need reliable and valid measurement tools.
Despite the prevalence of GTPS, the VISA-G, a condition-specific PROM tool has
only been published recently (Fearon et al., 2015). Previously surrogate tools have been
used to evaluate the severity of the condition, for example the modified Harris Hip
(mHHS) developed for hip osteoarthritis, and the Oswestry disability index, developed for
assessing back pain (Reid, 2016). However, the mHHS and the Oswestry disability
index have been shown to measure different domains than the VISA-G (Lustenberger et al.,
2011) emphasising the need for linguistically and culturally appropriate condition-specific
tools to be developed.
Translated versions of the appropriated developed and tested tools are needed when
intending to collect data from respondents with culturally and linguistically diverse
backgrounds from the index population. Researchers should ensure rigorous cultural
adaptation and translation occurs, confirming the equivalent constructs with a comparable
metric (Tsang, Royse & Terkawi, 2017).
The purpose of the VISA-G is to monitor patient outcomes and evaluate treatment
strategies for people with GTPS (REF). The VISA-G was constructed and tested with
the intention that it should be used as a whole, although segments of it may provide
clinicians with insight into how their clients are progressing. The VISA-G is based on the
Victorian Institute of Sport Assessment (VISA) questionnaire model, which, intern, is
based on item response theory, using graded responses (responses reflect increasing
difficulty) (An & Yung, 2014). The VISA questionnaire models are valid for the
assessment of other lower limb tendinopathies (Robinson Cook et al., 2001; Cacchio,
De Paulis & Maffulli, 2014; Hernandez-Sanchez, Hidalgo & Gomez, 2014), and across
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multiple languages and cultures (VISA-P (Maffulli et al., 2008a; Korakakis,
Patsiaouras & Malliaropoulos, 2014; Zwerver, Kramer & Van Den Akker-Scheek, 2009),
VISA-A (Lohrer & Nauck, 2009; Maffulli et al., 2008b; Iversen et al., 2016) and
VISA-H (Cacchio, De Paulis & Maffulli, 2014)). The The VISA-G questionnaire
(Fearon et al., 2015) is a product of a rigorous development process using the COSMIN
recommendations. The English version has good internal and intra-rater reliability,
and good content and construct validity; concurrent criterion validity has been
demonstrated (Fearon et al., 2015).
The purpose of the current study was to translate the VISA-G from English into the
Danish language (VISA-G.DK), to conduct a cross-cultural adaptation into a Danish
context, assessing validity in the Danish context, and to evaluate the VISA-G.DK
reliability.
MATERIALS AND METHODS
Ethical approval
The Ethics committee for North Jutland, Denmark, stated that no approval was necessary
as the study did not include an intervention. The study was approved by the Danish Data
Protection Agency (J.nr. 2018-42-4655). All participants provided written informed
consent. The study complied with the Declaration of Helsinki.
Translation procedure for the VISA-G questionnaire
The current authors have previously described the study design and methods, which follow
best practice guidelines (Jorgensen et al., 2016a; Jorgensen et al., 2016b; Beaton et al., 2000;
Wild et al., 2005).
In brief:
1. Permission. The developer of the VISA-G was approached to collaborate on the
translation process (Fearon et al., 2015).
2. Forward translation—data acquisition. Two independent bilingual native Danish
speakers and residents (T1 and T2), translated the questionnaires into Danish. T1 was a
physiotherapist aware of the concepts being examined, whereas T2 had no medical
training. The translation was overseen by a third bilingual researcher (JA).
3. Forward translation—Reconciliation. Separate meetings were held between the
third researcher and each of the translators (T1 and T2) to address discrepancies in the
forward translations. Issues identified in the translation process were identified (Beaton
et al., 2000) with any unresolved queries resolved after consultation with the developer
(Wild et al., 2005).
4. Back translation—data acquisition. The agreed-upon forward-translated versions of
the Danish questionnaire was then translated back into English by two native English
speakers resident in Denmark and fluent in Danish (BT1 and BT2). BT1 was a
physiotherapist, whereas BT2 had no medical training. BT1 and BT2 were both blinded to
the purpose of the questionnaire and had not seen the original VISA-G questionnaire
(Beaton et al., 2000).
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5. Back translation—Reconciliation. The translated versions were compared to the
original version to ensure conceptual equivalence; the remaining discrepancies and
ambiguities were resolved between the project managers (JA) (JEJ), BT1 and BT2.
6. Harmonisation. The harmonisation group consisted of the back- and forward
translators, a research physiotherapist (CM) and a bilingual competent physiotherapist
(JEJ). The project manager (JA) communicated with each member of the harmonisation
group individually by email due to geographic differences. Subsequently, through
group-email correspondence, the team agreed upon the harmonised version of the Danish
VISA-G of the VISA-G.DK questionnaire. All members of the harmonisation group
approved the translated versions.
7. Cultural validation. Cognitive interviews of five patients with a diagnose of GTPS, and
four physiotherapists with relevant clinical experience were conducted to assess the
harmonised version of the VISA-G.DK. A research physiotherapist trained in cognitive
interviewing (CM) conducted these interviews at the Department of Orthopaedic Surgery,
Aalborg University Hospital. A maximum of 24 h before the interview, each participant
completed the VISA-G.DK. The participant was then interviewed to establish how they
had interpreted the items. This process provided the opportunity to identify problem
questions, minimising future response errors and nonresponse (Beaton et al., 2000).
The interview method employed was ‘concurrent probing’ with the duration varying
between 10 and 35 min. During the interview, the participants were asked to verbalise their
thoughts and opinions while completing the questionnaire.
8. Cultural validation—Harmonisation. The results from the cognitive interviews
were reviewed, and a final translated version of each questionnaire prepared. Issues of
interpretation of the questionnaire were documented (Wild et al., 2005; Kuusela & Paul,
2000).
9. Final Translation. The version was were proofread and checked for spelling and
grammar errors. The layout was then finalized by the project manager and three research
physiotherapists (Beaton et al., 2000).
10. Documentation. The final report documenting the translation procedure was
finalised.
The VISA-G.DK questionnaire
The VISA-G.DK consists of eight questions (Appendix 1). The first question relates to hip
pain in general and is scored on a scale from 0 to 10. The remaining seven questions relate
to everyday activities and participation (International Classification of Functioning,
Disability and Health (ICF)). The activities and participation questions measure the
participants ability to lie on the sore hip, walk on stairs, walk on ramps or slopes, move
from sitting to walking, work about the house or garden, participate in regular exercise,
and weightbearing related pain and function. As with existing VISA scores, the first six
questions were scored between 0 and 10, while questions 7 and 8 are scored out of 10
and 30 respectively. Question 8 is divided into three subsections of which only one section
is required to be answered. The final score is calculated out of 100 (Appendix 2).
The higher the score the less the disability perceived by the individual.
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Participant recruitment
A sample of convenience was recruited at a physiotherapy private practice in Aalborg,
Denmark between June 2018 and May 2019.
Following screening for exclusion criteria: current or history of low back or hip pain
requiring them to seek treatment for that condition, the VISA-G.DK was sent to 63
asymptomatic participants, of whom 58 completed the online questionnaire twice, 1 week
apart (response rate, 92%). The asymptomatic group was heterogeneous, and included
respondents’ with no signs or symptoms of GTPS. The symptomatic group included
63 symptomatic patients presenting symptoms of hip pain in weight bearing and the
inability to lie on the affected side, of whom 49 completed the online questionnaire twice,
1 week apart (response rate, 78%).
Nonrespondents in both groups were prompted by a reminder e-mail 24 h after the deadline
for submission. Respondents failing to respond a second time were excluded (Table 1).
The the online questionnaire was completed using Survey Monkey (SurveyMonkey Inc.).
The security is deemed to be adequate for collecting nonsensitive personal information
(sex and age).
Score calculation
Scores were totalled as per the scoring sheet (Appendix 2). If a respondent answers all three
sections of question 8—the lowest activity scenario was scored (Section A), as per
recommended by the developer and in keeping with assuming a worst case scenario.
Cognitive interviews
Face to face cognitive interviews of five patients with GTPS and four experienced clinical
physiotherapists were performed to assess the harmonised version of the VISA-G.DK.
The patient’s GTPS diagnosis was confirmed as per Ganderton and colleagues (Ganderton
et al., 2017). The interviews were, recorded in writing according to the matrix suggested by
Conrad & Blair (1996) (Table 2).
Statistics
Based on an expected reliability of 0.90, assuming a power of 0.80 and a significance level of
0.05, we calculated that a total sample size of 49 symptomatic and asymptomoatic
Table 1 Respondents characteristics.
Asymptomatic Symptomatic
Respondents included (response rate %) 58 (92) 49 (78)
Age mean (±SD) 50 (±8.9) 56 (±10.2)
Gender/sex, n (%) 41 women, 17 men
(71% women, 29% men)
47 women, 2 men
(96% women, 4% men)
Time to complete questionnaire Round 1
Minutes: seconds range (average)
1:20–8:24 (±4:38) 2:36–9:56 (±4:45)
Time to complete questionnaire Round 2
Minutes: seconds range (average)
1:20–7:01 (±3:36) 2:12–8:38 (±3:49)
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respondents within the target age-group, would be required for test–retest reliability
(Walter, Eliasziw & Donner, 1998; Polit, 2014). To account for non-respondents, we aimed
to recruit 63 asymptomatic and 63 symptomatic participants (Polit, 2014).
Internal consistency was determined via Cronbach’s alpha with 0 indicating no internal
consistency and 1 corresponding to perfect internal consistency. A two-way random
effects model (2.1), with single measures and absolute agreement ICC, was used to express
reliability (Tsang, Royse & Terkawi, 2017; SurveyMonkey Inc.). As a coefficient of stability,
Pearson’s product moment correlation coefficient (Pearson’s r) was calculated with a
two-tailed test of significance. A larger coefficient value indicating stronger test–retest
reliability (Tsang, Royse & Terkawi, 2017; Draugalis & Plaza, 2009).
The standard error of measurement (SEM) was calculated by first creating a variable
for the difference between the total VISA-G.DK score obtained during the first and the
second round (test score—retest score = Difference). We then calculated the standard
deviation (SD) and the SEM of the Difference in the VISA-G.DK (SDDifference), as
suggested by the COSMIN guidelines (Polit, 2014; Terwee et al., 2018).
The mean (SD) and SEM difference were calculated for the test–retest results, as per
COSMIN guidelines (Polit, 2014; Terwee et al., 2018).
To interpret the reliability of the change in scores of the VISA-DK, the minimal
detectable change (MDC), representing the amount of score change beyond measurement
error, was calculated. The MDC represents a score ±1.96 times the SDDifference in the
test–retest scores of the VISA-G.DK (Polit, 2014).
Floor and ceiling effects were explored by assessing the distribution of total scores and
determining if more than 15% of the participants achieved either the lowest or the highest
score (McHorney & Tarlov, 1995).
Bland–Altman plots were used to assess agreement and heteroscedasticity (Bland &
Altman, 1986).
Statistics were performed by SPSS Statistics for Mac, version 24 (SPSS Inc., Chicago, IL,
USA).
RESULTS
Translation
No major problems were observed in the forward translations of the questionnaires and
only minor discrepancies were discussed in the harmonizing process, primarily consisting
Table 2 Matrix of recorded interviews in writing.
Response stage
Problem type Understanding Retrieval/decision Response formatting
Lexical X (question 1) X (question 8)
Inclusion/exclusion
Temporal X (question 2) X (question 8)
Logical X (question 8)
Computational
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of differences in the choice of synonyms and use of prepositions. Examples are: ‘Question
1: My usual hip pain is…/The current pain in my hip is….…’ ‘Question 2: I can lie on my
sore hip……/I can lie on my painful hip’ ‘Question 4: Walking up or down a ramp or
slope…./Walking up and down a ramp or incline’. After discussion and reaching
consensus on the most suitable wording the discrepancies were corrected.
Cognitive interviews
The results from the interview with the five patients with GTPS, and four physiotherapists
prompted no major changes in the questionnaire; only a few minor changes were
made. In question 1 the Danish word ‘sædvanlige’ was used to describe ‘usual pain’.
The patients had difficulty in deciding if the pain score related to the actual pain while
answering the questionnaire, or the question referred to their usual pain during the day.
This will be solved by making a point of this in the instruction manual and pointing out
that the question relates to the usual pain during the day. We also added the word
‘gennemsnitlige’, meaning average to the original term of ‘sædvanlige’.
Question 8 repeatedly posed problems in choosing which section to answer. It was
found confusing with three sections with almost the same wording. To clarify this section,
we have included a clarification question to each section:
Original version question 8, Section A:
‘Section A: My hip pain is so severe that it will stop me from walking, shopping, running
or other weight-bearing exercise. If this is so, how much of this activity do you do each
day?’
Clarification question 8, Section A:
Section A: Can you answer yes to the following question: ‘My hip pain is so severe
that it will stop me from walking, shopping, running or other weight-bearing exercise.
If this is so, how much of this activity do you do each day?’ then answer Section A. If you
cannot answer yes, proceed to Section B or C.
This clarification was repeated in Section B and C. The question is prioritised in the
instruction manual, making it clear to the tester to be sure that the patient understands the
construct of question 8 before answering it.
Additional amendments
In the original VISA-G time intervals in question 2 are ‘for longer than 1 h’, ‘for 30 min
to 1 h’, ‘for 15–30 min’, for 5–15 min’. This has been changed in the Danish version to: ‘for
longer than 60 min’, ‘for 30–59 min’, ‘for 15–29 min’, ‘for 5–14 min’, as this is in line
with the time intervals in question 8 Section A, B and C in the original VISA-G
questionnaire.
Total score
The score in the asymptomatic respondent population (VISA-G.DK n = 58) ranged from
86 to 100, out of a possible 100 points (mean = 98.00 and SD ± 4.05), retest (mean = 98.03
and SD ± 4.05).
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The score in the symptomatic respondent population (VISA-G.DK n = 49) ranged from
48 to 77, of a possible 100 points (mean = 61.94 and SD ± 5.78), retest (mean = 61.94 and
SD ± 5.78).
Validation and reliability
The asymptomatic respondent population Cronbach’s Alpha showed excellent internal
consistency (0.86). The test–retest reliability was excellent: ICC: 0.98 (95% CI [0.97–0.99]).
There was a positive correlation between the test and retest variables, n = 58, r = 0.98,
p = 0.01.
The symptomatic respondent population Cronbach’s Alpha showed excellent internal
consistency (0.98). The test–retest reliability was excellent: ICC: 0.96 (95% CI [0.93–0.98]).
There was a positive correlation between the test and retest variables, n = 49, r = 0.96,
p = 0.01.
MDC was found to be ±3.17. SEM was calculated to be 0.6.
No floor or ceiling effects were identified in the patient group with less than 15% of
participants scoring the minimum or maximum values. In the symptomatic group,
VISA-G.DK data were normally distributed. A total of 94% of the asymptomatic group
scored the maximum value, thus, data were not normally distributed.
Bland–Altman plots showed no significant or relevant differences from test to retest in
the total score with mean differences below 1 (0.612) (Fig. 1).
DISCUSSION
The purpose of the current study was to translate the VISA-G (Fearon et al., 2015) from
English into the Danish language (VISA-G.DK), to conduct a cross-cultural adaptation to
a Danish context and to assess the VISA-G.DK reliability.
Figure 1 Bland–Altman plot. Full-size DOI: 10.7717/peerj.8724/fig-1
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The VISA-G.DK has been shown to have an excellent internal consistency and a strong
test–retest reliability. The SEM at a 95% confidence interval is shown to be ±1.2 points.
This implies that ±1 SEM (68% confidence) of the ‘true’ score can be found between
±0.6 points from the observed score, and ±2 SEM (95% confidence) is between ±1.2 points
of the observed score.
The MDC is ±3.17. Therefore, a change in the VISA-G.DK score of at least 3.17 points
(on a scale of 0–100) would be considered to be a true change in the VISA-G.DK score,
and not a potential result of measurement error. The Bland–Altman plots showed no
significant from test to retest in the total score. No floor and ceiling effects were observed in
the patient group, however in the asymptomatic group an expected ceiling effect was
shown.
An internationally recommended translation procedure was used to produce a Danish
version of the VISA-G questionnaire (Fearon et al., 2015). The rigorous translation
methodology used ensured the questionnaire was translated and adapted into a Danish
context. Cognitive interviews were used to provide a face validation of the translated
versions of the VISA-G (Fearon et al., 2015), thereby minimizing non-responses and
response errors (Wild et al., 2005). No major problems were observed in the forward and
backward translations of the questionnaires.
The goal for test–retest reliability assessments is to distinguish true score differences
from random and transitory measurement error (Polit, 2014). Studies of test–retest
reliability for health-related QOL instruments have used varying intervals between test
administrations, with an earlier study showing no statistically significant differences in
test–retest reliability studies undertaken between 2 days and 2 weeks (Marx et al., 2003).
We chose to use a 1 week between test and retest interval for practical reasons at the clinic
involved.
The test–retest respondents were chosen within the population most often affected by
GTPS (Fearon et al., 2014a; Barratt, Brookes & Newson, 2017). Recruiting respondents
who were asymptomatic, ensured that the test–retest testing was based on the
understanding of the questionnaire, thus further validating the translation. We also
recruited symptomatic participants as this is the target population and fluctuating pain or
functional responses between the 2-time intervals may cause validation and reliability
scores to deflate (Tsang, Royse & Terkawi, 2017;Marx et al., 2003). In this study there were
no major differences in reliability between the symptomatic and asymptomatic group.
Function or pain, within the symptomatic group, would not be expected to vary to a large
extent within the 1-week time span between test and retesting, thereby these factors are
unlikely to have influenced the reliability.
The VISA-G.DK was found to have high levels of intra-rater reliability and internal
consistency. These data are consistent with the English version of the VISA-G
(Fearon et al., 2015) and the VISA-H (Cacchio, De Paulis & Maffulli, 2014). In addition,
the VISA-G.DK like the English version (Fearon et al., 2015) is resistant to ceiling and floor
effects, which is not the case with the English version of the mHHS or the Oswestry
Disability Index, two other scores commonly used to assess GTPS and gluteal tendon tears
(Ebert et al., 2019). Further, we are the first to report the MDC and the SEM for any version
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of the VISA-G. This means that clinicians who see a change of greater than 3 can be
confident that this is a real change, not change due to measurement variation.
The testing of the VISA-G.DK was undertaken on a suitable sample size, meaning we
have minimised the possibility of response bias in test–retests (Draugalis & Plaza, 2009).
The sample size calculation suggested that a minimum of 49 respondents was needed for
our primary analyses (Walter, Eliasziw & Donner, 1998; Polit, 2014; De Vet et al., 2011).
The recruitment of 63 people per group and the high response rate, well above the
minimum required (50–60%) (Draugalis & Plaza, 2009) meant we were well within the
calculated 49 per group. The response rate of 78% the symptomatic group differs
compared to the asymptomatic group; however the minimum number of respondents was
met.
The Danish versions were completed within 1:20 and 8:24 min for the asymptomatic
group of respondents and between 2:36 and 9:56 for the symptomatic group, thereby the
VISA-G.DK seems feasible and field-friendly for investigating and monitoring GTPS
pain and function. The test–retest study showed substantial agreement between test and
retest in the non-symptomatic respondent group.
CONCLUSION
The translated version of the VISA-G.DK questionnaire was linguistically and culturally
equivalent to the original version. The translated score showed good reliability.
Limitation
The 1-week period between test and retest may have induced recall bias, however, if this
period was extended, pain and function scores may have changed due to other factors
than cognitive understanding of the questionnaire. In an earlier study by Frohm et al.
(2004) examining the VISA-P, the majority of participants (66%) were asymptomatic.
Perspectives
Publishing the translation of a health measurement instrument is important to avoid
the emergence of multiple versions of the instrument and to demonstrate that the
translation procedure was rigorous. It also facilitates the comparison of findings between
and within countries (Marshall et al., 2000). The translation of the VISA-G.DK to a
Danish version was performed using rigorous methodology, adapted culturally, and face
validated to a Danish context. Further research should be used to establish the
psychometric properties of the VISA-G.DK in a clinical setting with a relevant sample of
patients with established GTPS. An ongoing study (N-20180036. Clinical Predictors of
Extracorporal Shockwave Therapy Efficacy in patients presenting with lateral hip pain)
will endeavour to do this.
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